Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 6/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.36 |
| ▸ | BAD | Q92934 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29424782 | 1.00 | DRD1 (0.39) | DRD1CYP3A4TDP1TSHRCES1 | |
| SCHEMBL29924184 | 1.00 | DRD1 (0.39) | DRD1CYP3A4TDP1TSHRCES1 | |
| Iodide SCHEMBL9231383 | 0.98 | DRD1 (0.38) | DRD1CYP3A4TDP1TSHRCES1 | |
| Iodide SCHEMBL9231386 | 0.98 | DRD1 (0.38) | DRD1CYP3A4TDP1TSHRCES1 | |
| SCHEMBL9192628 | 0.98 | DRD1 (0.38) | DRD1CYP3A4TDP1TSHRCES1 | |
| SCHEMBL14356045 | 0.96 | DRD1 (0.39) | DRD1CYP3A4TDP1TSHRCES1 | |
| Carbon Monoxide SCHEMBL9194161 | 0.92 | CES1 (0.36) | DRD1CYP3A4TDP1TSHRCES1 | |
| SCHEMBL7030489 | 0.92 | BCL2L1 (0.42) | DRD1CYP3A4TDP1TSHRCES1 | |
| Hydrochloric Acid SCHEMBL9191831 | 0.91 | DRD1 (0.37) | DRD1CYP3A4TDP1TSHRCES1 | |
| Acetic Acid SCHEMBL30315806 | 0.91 | DRD1 (0.37) | DRD1CES1BCL2L1BADMETAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710422-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-07 | — | — | EP | claimed |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-06 | — | — | US | claimed |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-12-31 | — | — | US | claimed |
| EP-2482978-B1 | HETEROGENEOUS RHODIUM METAL CATALYSTS | UNIV ALBERTA (CA) | 2018-05-09 | — | — | EP | claimed |
| US-8962516-B2 | Heterogeneous rhodium metal catalysts | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (US) | 2015-02-24 | — | — | US | claimed |
| US-20130053576-A1 | HETEROGENEOUS RHODIUM METAL CATALYSTS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 2013-02-28 | — | — | US | claimed |
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2010-12-09 | — | — | US | claimed |
| EP-1650207-B1 | Process for producing optically active 3-quinuclidinols | TAKASAGO PERFUMERY CO LTD (JP) | 2007-06-27 | — | — | EP | claimed |
| US-5922918-A | Method for making an optically active diphosphine ligand | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-07-13 | — | — | US | claimed |
| US-5919962-A | CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-07-06 | — | — | US | claimed |
| EP-0839819-A1 | Method of preparing optically active diphosphine ligands | Takasago International Corporation (JP) | 1998-05-06 | — | — | EP | claimed |
| EP-0781749-A2 | Process for producing optically active benzhydrol compounds | Takasago International Corporation (JP) | 1997-07-02 | — | — | EP | claimed |
| EP-0479542-B1 | A phosphino binaphthyl compound and transition metal complexes thereof | TAKASAGO PERFUMERY CO LTD (JP) | 1995-11-29 | — | — | EP | claimed |
| US-5206399-A | 2,2'-BIS(DIPHENYLPHOSPHINO)-5,5',6,6',7,7',8,8'-OCTAHYDRO-1,1'-BINAPHTHYL AND TRANSITION METAL COMPLEX CONTAINING THE SAME AS LIGAND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1993-04-27 | — | — | US | claimed |
| EP-0479542-A1 | A phosphino binaphthyl compound and transition metal complexes thereof | Takasago International Corporation (JP) | 1992-04-08 | — | — | EP | claimed |
| JP-4139140-A | — | — | None | — | — | JP | disclosed |
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2026-05-07 | — | — | US | disclosed |
| US-5206399-A | 2,2'-BIS(DIPHENYLPHOSPHINO)-5,5',6,6',7,7',8,8'-OCTAHYDRO-1,1'-BINAPHTHYL AND TRANSITION METAL COMPLEX CONTAINING THE SAME AS LIGAND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1993-04-27 | — | — | US | disclosed |
| US-5206399-A | 2,2'-BIS(DIPHENYLPHOSPHINO)-5,5',6,6',7,7',8,8'-OCTAHYDRO-1,1'-BINAPHTHYL AND TRANSITION METAL COMPLEX CONTAINING THE SAME AS LIGAND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1993-04-27 | — | — | US | disclosed |
| JP-H04139140-A | 2,2'-BIS(DIPHENYLPHOSPHINO)-5,5',6,6',7,7',8,8'-OCTAHYDRO-1,1'-BINAPHTHYL AND TRANSITION METALLIC COMPLEX CONTAINING THE SAME AS LIGAND | TAKASAGO INTERNATL CORP | 1992-05-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SLC26A4, SLC26A3 | DRD1 350/4885CYP3A4 2604/4885TDP1 3069/4885 |
| US-20130053576-A1 | HETEROGENEOUS RHODIUM METAL CATALYSTS | RRM2, RRM2B, RRS1 | DRD1 1907/4885CYP3A4 2854/4885TDP1 1474/4885 |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | TBCB, ADORA2B, ADRA2B | DRD1 298/4885CYP3A4 418/4885TDP1 4095/4885 |
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | AP2M1, OPRM1, CD81 | DRD1 1797/4885CYP3A4 4218/4885TDP1 2120/4885 |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | TBCB, ADORA2B, CCNB3 | DRD1 158/4885CYP3A4 519/4885TDP1 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.